Showing results (61-70 of 635) with videos related to

Sort By:
Pageof 64
Physics in Medicine and Biology|March 6, 2014
Self-irradiation of the blood from selected nuclides in nuclear medicineH Hänscheid, M Fernández, U Eberlein, et al.
Nuklearmedizin. Nuclear Medicine|February 16, 2005
Staging in childhood lymphoma: differences between FDG-PET and CTS Hermann, D Wormanns, M Pixberg, et al.
The Thoracic and Cardiovascular Surgeon|April 28, 2006
Mucinous cystadenocarcinoma--an extremely rare tumor in a young patientO Sezer, A Hoffmeier, O Bettendorf, et al.
Nuclear Medicine and Biology|April 11, 2001
Characterization of 3-[123I]iodo-L-alpha-methyl tyrosine ([123I]IMT) transport into human Ewing's sarcoma cells in vitroC Franzius, K Kopka, F van Valen, et al.
Archives of Disease in Childhood|June 23, 2005
The presence of vesicoureteric reflux does not identify a population at risk for renal scarring following a first urinary tract infectionI Moorthy, M Easty, K McHugh, et al.
European Radiology|February 2, 2006
Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules?K U Juergens, M Weckesser, L Stegger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CTC Franzius, H E Daldrup-Link, J Sciuk, et al.
Nuklearmedizin. Nuclear Medicine|February 19, 2008
Whole-body imaging of oncologic patients using 16-channel PET-CT. Evaluation of an i.v. contrast enhanced MDCT protocolK U Juergens, M L Oei, M Weckesser, et al.
Nuklearmedizin. Nuclear Medicine|December 18, 2010
(131)I therapy in patients with benign thyroid disease does not conclusively lead to a higher risk of subsequent malignanciesF A Verburg, M Luster, M Lassmann, et al.
Nuklearmedizin. Nuclear Medicine|October 17, 2007
[Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer]C Franzius, M Dietlein, M Biermann, et al.
Pageof 64